Nalaganje...
Targeting TFPI for hemophilia treatment
Hemophilia is a severe bleeding disorder treated by infusion of the missing blood coagulation protein, factor VIII or factor IX. The discovery and characterization of the anticoagulant protein tissue factor pathway inhibitor (TFPI) led to the realization that inhibition of TFPI activity could restor...
Shranjeno v:
| izdano v: | Thromb Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950664/ https://ncbi.nlm.nih.gov/pubmed/27207418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0049-3848(16)30359-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|